Insider · CIK 0001311210

Machado Patrick

Reports to the SEC for 18 companies · SOUTH SAN FRANCISCO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001311210

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-30	ALMSALUMIS INC.A Award	Director	AAward	+3,553 sh	—	—	3,553
2026-06-30	ALMSALUMIS INC. · Stock Option (Right to Buy)A Award	Director	AAward	+15.5K sh	—	—	15,528
2026-06-11	RCUSArcus Biosciences, Inc.A Award	Director	AAward	+5,700 sh	—	—	44,300
2026-06-11	RCUSArcus Biosciences, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+16.9K sh	—	—	16,900
2026-06-03	XENEXenon Pharmaceuticals Inc. · Share Option (Right to Buy)A Award	Director	AAward	+10.5K sh	—	—	10,507
2026-06-03	XENEXenon Pharmaceuticals Inc. · Restricted Share UnitsA Award	Director	AAward	+1,593 sh	—	—	1,593
2026-06-01	XENEXenon Pharmaceuticals Inc.M Exercise/Conversion	Director	MExercise/Conversion	+2,645 sh	—	—	2,645
2026-06-01	XENEXenon Pharmaceuticals Inc. · Restricted Share UnitsM Exercise/Conversion	Director	MExercise/Conversion	−2,645 sh	—	—	0
2025-12-09	Adverum Biotechnologies, Inc.U Disposition from Tender	Director	UDisposition from Tender	−8,818 sh	—	—	0
2025-12-09	Adverum Biotechnologies, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−1,000 sh	—	—	0
2025-12-09	Adverum Biotechnologies, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−6,476 sh	—	—	0
2025-12-09	Adverum Biotechnologies, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−3,360 sh	—	—	0
2025-12-09	Adverum Biotechnologies, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−3,500 sh	—	—	0
2025-12-09	Adverum Biotechnologies, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−4,500 sh	—	—	0
2025-12-09	Adverum Biotechnologies, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−1,500 sh	—	—	0
2025-12-09	Adverum Biotechnologies, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−3,000 sh	—	—	0
2025-12-09	Adverum Biotechnologies, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−5,250 sh	—	—	0
2025-12-09	Adverum Biotechnologies, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−5,250 sh	—	—	0
2025-12-09	Adverum Biotechnologies, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−5,250 sh	—	—	0
2025-12-09	Adverum Biotechnologies, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−13.8K sh	—	—	0
2025-12-09	Adverum Biotechnologies, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−13.6K sh	—	—	0
2025-07-30	ALMSALUMIS INC. · Stock Option (Right to Buy)A Award	Director	AAward	+49.8K sh	—	—	49,800
2025-06-17	Adverum Biotechnologies, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+10.5K sh	—	—	10,450
2025-06-17	Adverum Biotechnologies, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+3,140 sh	—	—	3,140
2025-06-10	RCUSArcus Biosciences, Inc.A Award	Director	AAward	+13.3K sh	—	—	38,600
2025-06-10	RCUSArcus Biosciences, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+38.3K sh	—	—	38,300
2025-06-05	XENEXenon Pharmaceuticals Inc. · Share Option (Right to Buy)A Award	Director	AAward	+17K sh	—	—	17,012
2025-06-05	XENEXenon Pharmaceuticals Inc. · Restricted Share UnitsA Award	Director	AAward	+2,645 sh	—	—	2,645
2025-05-21	ALMSALUMIS INC.A Award	Director	AAward	+7,064 sh	—	—	7,064
2025-05-21	ALMSALUMIS INC. · Stock Option (Right to Buy)A Award	Director	AAward	+44.4K sh	—	—	44,364
2025-05-21	ALMSALUMIS INC. · Stock Option (Right to Buy)A Award	Director	AAward	+11.2K sh	—	—	11,189
2025-05-21	ALMSALUMIS INC. · Stock Option (Right to Buy)A Award	Director	AAward	+41.5K sh	—	—	41,499
2025-05-21	ALMSALUMIS INC. · Stock Option (Right to Buy)A Award	Director	AAward	+13.8K sh	—	—	13,804
2025-05-21	ALMSALUMIS INC. · Stock Option (Right to Buy)A Award	Director	AAward	+19.5K sh	—	—	19,528
2025-05-21	ACELYRIN, Inc.D Disposition to Issuer	Director	DDisposition to Issuer	−14.7K sh	—	—	0
2025-05-21	ACELYRIN, Inc.Director Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−92.2K sh	—	—	0
2025-05-21	ACELYRIN, Inc.Director Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−23.2K sh	—	—	0
2025-05-21	ACELYRIN, Inc.Director Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−28.7K sh	—	—	0
2025-05-21	ACELYRIN, Inc.Director Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−86.2K sh	—	—	0
2025-05-21	ACELYRIN, Inc.Director Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−40.6K sh	—	—	0
2024-07-01	ALMSALUMIS INC. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−38K sh	—	—	0
2024-07-01	ALMSALUMIS INC. · Stock Option (Right to Buy)A Award	Director	AAward	+38K sh	—	—	38,000
2024-06-27	ALMSALUMIS INC. · Stock Option (Right to Buy)A Award	Director	AAward	+38K sh	—	—	38,000
2024-06-17	Adverum Biotechnologies, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+10.5K sh	—	—	10,520
2024-06-17	Adverum Biotechnologies, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+3,300 sh	—	—	3,300
2024-06-07	ACELYRIN, Inc.Director Stock Option (right to buy)A Award	Director	AAward	+92.2K sh	—	—	92,158
2024-06-06	RCUSArcus Biosciences, Inc.A Award	Director	AAward	+8,400 sh	—	—	25,300
2024-06-06	RCUSArcus Biosciences, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+24K sh	—	—	24,000
2024-06-05	XENEXenon Pharmaceuticals Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+15.5K sh	—	—	15,542
2023-10-04	ACELYRIN, Inc.J Other	Director	JOther	+14.7K sh	—	—	14,675

Recent filings

Accepted (ET)
Jul 24
Machado Patrick0001311210-26-000006
SEC(opens sec.gov)
Jun 124
Machado Patrick0001311210-26-000003
SEC(opens sec.gov)
Jun 34
Machado Patrick0001193125-26-256125
SEC(opens sec.gov)
Dec 104
Machado Patrick0001311210-25-000004
SEC(opens sec.gov)

Companies

Address

C/O ALUMIS INC. 280 EAST GRAND AVENUE

SOUTH SAN FRANCISCO, CA, 94080